This Leading Healthcare Stock Earns a Top Rating (Strong Buy): Reasons It Deserves Your Attention

Building a Winning Investment Portfolio

No matter your investment style—whether you focus on growth, value, income, or momentum—achieving success in the stock market requires a blend of expertise, thorough analysis, and a touch of good fortune.

But how do you select the ideal mix of stocks? Securing your financial future, from retirement to your children’s education and both short- and long-term savings, depends on generating strong returns.

Introducing the Zacks Rank System

The Zacks Rank is a proprietary stock rating system designed to help investors assemble high-performing portfolios by analyzing changes in earnings estimates.

This model is built on four core components:

• Agreement: Measures how consistently analysts are adjusting their earnings forecasts in the same direction. The more analysts raising their estimates, the higher the likelihood of outperformance.
• Magnitude: Assesses the size of recent changes in consensus earnings estimates for the current and upcoming fiscal years.
• Upside: Compares Zacks’ most accurate estimate with the broader consensus estimate.
• Surprise: Looks at a company’s recent earnings surprises, with positive surprises suggesting a greater chance of future outperformance.

Each factor receives a score that is updated nightly, and these are combined to determine the Zacks Rank. Stocks are then sorted into five categories, from “Strong Buy” to “Strong Sell.”

The Influence of Institutional Investors

The Zacks Rank empowers individual investors to leverage the strategies of institutional investors—those who manage vast sums in hedge funds, mutual funds, and investment banks. Because their trades involve such large amounts, institutional investors often influence market direction.

These professionals use detailed valuation models based on earnings and future expectations to determine a company’s fair value. When earnings estimates rise, so does the perceived value of a company.

Institutional investors typically respond to upward earnings revisions by buying, and to downward revisions by selling. This behavior can drive stock prices higher, benefiting investors who act early.

Since it can take institutions weeks or even months to build their positions, individual investors who react promptly to positive estimate revisions can gain an edge and potentially profit from the subsequent institutional buying.

The Zacks Rank not only helps you spot these trends but also highlights stocks that are attracting professional interest.

Applying the Zacks Rank to Your Investments

The Zacks Rank has a strong track record of enhancing portfolio performance. For example, a portfolio of Zacks Rank #1 (Strong Buy) stocks has outperformed the market in 26 of the past 32 years, delivering an average annual return of 23.86%.

Stocks newly upgraded to #1 (Strong Buy) often present significant upside, while those downgraded to #4 (Sell) or #5 (Strong Sell) may underperform.

Consider Intuitive Surgical, Inc. (ISRG), which was added to the Zacks Rank #1 list on January 29, 2026. Based in Sunnyvale, California, Intuitive Surgical develops and markets the da Vinci robotic surgical system, the Ion endoluminal system, and related tools. The da Vinci system includes a surgeon’s console, a patient-side cart, a 3D vision system, a skills simulator, and Firefly Fluorescence Imaging.

Over the past 60 days, 10 analysts have raised their earnings forecasts for fiscal 2026, pushing the Zacks Consensus Estimate up by $0.46 to $10.07 per share. ISRG has delivered an average earnings surprise of 13.2%.

For the current year, earnings are projected to climb 12.8%, with revenue expected to grow by 14.9%.

Notably, ISRG’s share price has risen 3.9% in the last month, outperforming the S&P 500, which declined by 1.3% over the same period.

Key Takeaways

With its top-tier #1 (Strong Buy) rating, consistent upward earnings revisions, and robust price momentum, Intuitive Surgical, Inc. stands out as a compelling choice for investors.